Search

Your search keyword '"Haga H"' showing total 5 results
Start Over Author "Haga H" Journal annals of oncology
5 results on '"Haga H"'

1. 1776P Immune microenvironment, homologous recombination deficiency and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: JBCRG22 TR

Author

Ueno, T., primary, Kitano, S., additional, Masuda, N., additional, Ikarashi, D., additional, Yamashita, M., additional, Kadoya, T., additional, Bando, H., additional, Yamanaka, T., additional, Ohtani, S., additional, Nagai, S., additional, Nakayama, T., additional, Takahashi, M., additional, Saji, S., additional, Aogi, K., additional, Velaga, R.M., additional, Kawaguchi, K., additional, Morita, S., additional, Haga, H., additional, Ohno, S., additional, and Toi, M., additional

Published
2021
Full Text
View/download PDF

2. 147P Genomic profile and response prediction of eribulin mesylate-based neoadjuvant chemotherapy in triple-negative breast cancer patients

Author

Nishimura, T., primary, Masuda, N., additional, Kawaguchi, K., additional, Takada, M., additional, Maeshima, Y., additional, Tanaka, S., additional, Velaga, R., additional, Kikawa, Y., additional, Kadoya, T., additional, Bando, H., additional, Nakamura, R., additional, Yamamoto, Y., additional, Ueno, T., additional, Yasojima, H., additional, Ishiguro, H., additional, Morita, S., additional, Ohno, S., additional, Haga, H., additional, Ogawa, S., additional, and Toi, M., additional

Published
2021
Full Text
View/download PDF

3. 142P Long-term follow-up of neoadjuvant dual anti-HER2 therapy with trastuzumab and lapatinib plus paclitaxel, with or without endocrine therapy for HER2-positive primary breast cancer: Neo-LaTH (JBCRG-16) study

Author

Fujisawa, T., primary, Masuda, N., additional, Yamamoto, N., additional, Iwata, H., additional, Bando, H., additional, Aruga, T., additional, Tokunaga, E., additional, Ohtani, S., additional, Takano, T., additional, Inoue, K., additional, Suganuma, N., additional, Takada, M., additional, Aogi, K., additional, Sakurai, K., additional, Shigematsu, H., additional, Kuroi, K., additional, Haga, H., additional, Ohno, S., additional, Morita, S., additional, and Toi, M., additional

Published
2021
Full Text
View/download PDF

4. 1766P Longitudinal alteration of cytokine profile in the peripheral blood and clinical response for neoadjuvant chemotherapy in triple-negative breast cancer patients (translational research of the JBCRG-22 trial)

Author

Kawaguchi, K., primary, Masuda, N., additional, Tanaka, S., additional, Bando, H., additional, Nishimura, T., additional, Kadoya, T., additional, Yamanaka, T., additional, Imoto, S., additional, Velaga, R., additional, Tamura, N., additional, Aruga, T., additional, Maeshima, Y., additional, Takada, M., additional, Suzuki, E., additional, Ueno, T., additional, Ogawa, S., additional, Haga, H., additional, Ohno, S., additional, Morita, S., additional, and Toi, M., additional

Published
2021
Full Text
View/download PDF

5. 163MO Randomized phase II study of eribulin-based neoadjuvant chemotherapy for triple-negative primary breast cancer patients stratified by homologous recombination deficiency status (JBCRG-22)

Author

Bando, H., primary, Masuda, N., additional, Yamanaka, T., additional, Kadoya, T., additional, Takahashi, M., additional, Nagai, S., additional, Ohtani, S., additional, Aruga, T., additional, Suzuki, E., additional, Kikawa, Y., additional, Yasojima, H., additional, Kasai, H., additional, Ishiguro, H., additional, Kawabata, H., additional, Morita, S., additional, Haga, H., additional, Kataoka, T.R., additional, Uozumi, R., additional, Ohno, S., additional, and Toi, M., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results